Skip to main content
Clinical Trials/IRCT20210608051514N2
IRCT20210608051514N2
Not yet recruiting
未知

The impact of prefrontal tRNS on schizophrenia clinical symptoms and cognitive deficits

Zanjan University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Zanjan University of Medical Sciences
Enrollment
40
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\- Having the ability of informed consent to participate in research
  • 2\_Have a minimum age of 18 and a maximum of 65 years
  • 3\_have a diagnosis of schizophrenia or schizoaffective disorder
  • 4\_ The same dose and drug used before the start and during the research
  • 5\_ Being right\-handed
  • 6\_ Stabilization in drug treatment for at least 7 weeks

Exclusion Criteria

  • 1\_Have a history of suicide and abuse of alcohol and substances other than caffeine and tobacco
  • 2\_Have a history of neurological diseases
  • 3\_Have a disease related to the scalp
  • 4\_Have a history of head trauma
  • 5\_ Existence of device or tool in the head
  • 6\- Leaving the research after being absent in two consecutive sessions
  • 7\- Pregnancy or breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials